Christopher Louis Hall, PHD

Christopher Louis Hall, PhD has a strong background in research and academia. Christopher Louis worked as a Graduate Student at The University of Texas Health Science Center at Houston (UTHealth) from 1995 to 2001. Christopher Louis then moved on to the University of Michigan, where they held various roles including Research Investigator and Postdoctoral Fellow in the Department of Urology from 2001 to 2011. During this time, they conducted research on mechanisms that regulate bone formation within prostate cancer skeletal metastases and contributed to the publication of multiple abstracts and papers in peer-reviewed journals. Christopher Louis also received invitations and travel awards to present their work at national scientific meetings. From 2011 to 2014, Dr. Hall worked as a Research Assistant Professor at the University of Massachusetts Medical School, Department of Cell and Developmental Biology. Here, they focused on host microenvironmental factors affecting tumor cell dormancy and progression within prostate cancer skeletal metastases. Christopher Louis played a key role in the design and monitoring of independent research projects, published multiple abstracts and a senior author paper, and presented their findings at national meetings. In 2015, Dr. Hall became a Research Assistant Professor at the University of Massachusetts Amherst, where they continued their research. Most recently, in 2018, they joined Ernest Pharmaceuticals as the Director of Preclinical Models. Overall, Dr. Hall's work experience demonstrates their expertise in cancer research, specifically in the field of prostate cancer metastasis to the bone, and their ability to lead and contribute to impactful research projects.

Christopher Louis Hall, PhD obtained their Bachelor of Science (BSc) degree in Biological Science with Specialization in Molecular Biology and Genetics from Purdue University, where they studied from 1987 to 1991. Christopher Louis then pursued their higher education at The University of Texas Health Science Center at Houston (UTHealth Houston), where they completed their Doctorate of Philosophy (PhD) in Cancer Biology from 1995 to 2001. Following their PhD, there is no specific information available about their timeline or duration, but they engaged in Postdoctoral Training in the Postdoctoral Translational Scholars Program at the University of Michigan.